MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Atherectomy and Intravascular Lithotripsy for Calcium Modification
Pros, cons, and situations when one technology might be better than another.
By Kathleen Kearney, MD, and Taishi Hirai, MD
Contrast-Enhanced Echocardiography for Evaluating Coronary Artery Perforations
A guide to the use of echocardiography with ultrasound-enhancing agents to aid in the management of coronary artery perforations.
By Jesse A. Kane, MD; Kathleen Kearney, MD; and Jasleen Tiwana, MD
Complex PCI
By Rhian E. Davies, DO, MS, FACC, FSCAI
Teleflex Ringer Perfusion Balloon Catheter’s PTCA Study Completes Enrollment
July 19, 2023—Teleflex Incorporated announced the completion of patient enrollment in the prospective multicenter Ringer percutaneous transluminal coronary angioplasty (PTCA) study, which is one of two clinical studies evaluating the performance of the company’s Ringer perfusion balloon catheter.
Technical Expertise as Shared Knowledge
By Kathryn Dawson, MD, and Azeem Latib, MD
FastWave Announces Medical Advisor Appointments and Pipeline Update
March 6, 2024—FastWave Medical Inc., a device company focused the treatment of calcified cardiovascular disease through intravascular lithotripsy (IVL), recently announced the appointments of eight medical advisors.
Teleflex’s Ringer Perfusion Balloon Catheter Receives FDA Clearance
July 31, 2024—Teleflex Incorporated announced FDA 510(k) clearance of the Ringer perfusion balloon catheter (PBC) for percutaneous transluminal coronary angioplasty (PTCA).
Hemodynamic Support for High-Risk PCI
Patient selection and procedural strategy are key in treating this evolving patient population.
By Kathleen E. Kearney, MD; James M. McCabe, MD; and Robert F. Riley, MD, MS
Funding for this supplement provided by CSI
Orbital Atherectomy in PCI for Calcific Disease: What Have We Learned and Where Are We Headed?
A data review on the role of orbital atherectomy in PCI for calcific coronary disease.
By Kathleen E. Kearney, MD
Reflow Medical Commences DEEPER CORONARY Pilot Study of Spur Elute Retrievable Scaffold
July 1, 2024—Reflow Medical, Inc. announced that the first patients were enrolled in DEEPER CORONARY, a pilot study of the company’s Spur Elute sirolimus-eluting retrievable scaffold system as a primary treatment for in-stent restenosis (ISR) of the coronary arteries.
Radial Artery Access
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Reflow Launches CoraCatheters Line of Microcatheters for Complex PCI
May 18, 2023—Reflow Medical, Inc. announced that it has received FDA clearance for its CoraCatheters line of microcatheters that are designed to access and cross complex and challenging lesions in percutaneous coronary intervention (PCI).
